A complex neurobiological disorder — not a weakness. Arising from dysfunction in cortico-limbic
circuits and neurotransmitter systems, depression is entirely treatable with a personalised
combination of medications, neuroplasticity enhancement, and lifestyle intervention.
Persistent low mood, anhedonia, and somatic symptoms affecting daily function for two or more weeks.
Not responding to two or more antidepressant trials — a key indication for neuroplasticity enhancement.
Affects up to 40% of stroke survivors — requiring integrated neurological and psychiatric management.
A core non-motor feature driven by dopaminergic and serotonergic pathway degeneration.
Pain and depression share overlapping neural circuits — each worsening the other in a reinforcing cycle.
Depression frequently co-occurs with anxiety, requiring integrated management of both.
Thorough clinical interview, PHQ-9/HAM-D severity rating, cognitive screening, thyroid and metabolic bloods, MRI
where indicated, and full medication history — combined to build a personalised treatment plan.
Personalised layered approach — medications stabilise, neuroplasticity restores, lifestyle sustains
In neurological depression (post-stroke, Parkinson’s, chronic pain), medication selection and therapy parameters are
carefully personalised to avoid interactions and address the underlying neurological mechanisms.
We deliver targeted energy to the dorsolateral prefrontal cortex (DLPFC) — the key region implicated in mood
regulation. This promotes neuroplastic reorganisation of cortico-limbic circuits, restoring the prefrontal control over
limbic hyperactivity that drives depression. Particularly effective in treatment-resistant and neurological depression.
Non-invasive, no systemic side effects, and personalised to each patient.
SSRIs, SNRIs, and adjuncts are selected based on symptom profile, comorbidities, and prior response. In
neurological depression, medication is carefully tailored to the underlying disease — personalised to each patient’s full
clinical picture.
Increases BDNF, serotonin, and dopamine — a proven antidepressant effect
Sleep hygiene Consistent sleep scheduling regulates the stress axis and treatment response
Anti-inflammatory nutrition supports the gut-brain axis
and reduces neuroinflammation
Reduces rumination and enhances prefrontal cortical regulation of mood
With personalised medications, neuroplasticity enhancement, and sustained lifestyle change, patients experience meaningful improvement in mood, energy, sleep, and cognition. In neurological depression, our integrated approach addresses the condition at its biological root.
| What Makes Our Practice Different | |||||
|---|---|---|---|---|---|
|
Personalised Protocols
Every plan tailored to the individual
|
Advanced Technology
Cutting-edge non-invasive therapeutic science
|
Mechanism-Based Care
We treat biology, not just symptoms
|
23+ Years Experience
Decades of specialist clinical wisdom
|
Whole Person Approach
Mind, body & lifestyle integrated
|
Objective Outcomes
Measurable results — not just relief
|
Mood disorders are complex mental health conditions that disrupt emotional stability, often leading to persistent sadness, irritability, or intense mood fluctuations. Common conditions include depression, bipolar disorder, and anxiety-related mood changes, all of which can significantly impact one’s personal,
Every recovery journey begins with a detailed clinical and neurological assessment by Dr. Sreekanth Vemula, a senior neurophysician with over 26 years of experience in treating neurological and neuropsychiatric disorders.
His evaluation includes:
This precise assessment ensures an accurate diagnosis and a fully personalized care plan.
Treatment is comprehensive and tailored to each patient’s needs.
It may include:
For patients experiencing mood-related neurological symptoms such as muscle tension or dystonia, Botulinum Toxin (Botox) injections are available to improve comfort and mobility.